Skip to search formSkip to main contentSkip to account menu

Vitamin K Epoxide Reductase

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Long-term use of warfarin has been shown to be associated with a reduced risk of prostate cancer. Warfarin belongs to the vitamin… 
Highly Cited
2012
Highly Cited
2012
Ero1 oxidation of PDI family members drives disulfide bond formation, but parallel pathways support Ero1 function. Relative… 
Highly Cited
2010
Highly Cited
2010
Vitamin K epoxide reductase (VKOR) generates vitamin K hydroquinone to sustain γ-carboxylation of many blood coagulation factors… 
Highly Cited
2006
Highly Cited
2006
More than 21 million prescriptions for warfarin are written yearly in the U.S. Despite its importance, warfarin's target, vitamin… 
Highly Cited
2005
Highly Cited
2005
Vitamin K epoxide reductase (VKOR) catalyzes the conversion of vitamin K 2,3-epoxide into vitamin K in the vitamin K redox cycle… 
2005
2005
Previously we reported that we could increase the fraction of carboxylated factor X by reducing the affinity of the propeptide… 
2005
2005
Vitamin K epoxide reductase (VKOR) is a newly identified protein which has been reported to convert the epoxide of vitamin K back… 
Highly Cited
1997
Highly Cited
1997
γ-Carboxylation of vitamin K-dependent proteins requires a functional vitamin K cycle to produce the active vitamin K cofactor…